Please login to the form below

I have forgotten my password

Autolus

This page shows the latest Autolus news and features for those working in and with pharma, biotech and healthcare.

Bicycle Therapeutics looks to raise $86m with IPO

Bicycle Therapeutics looks to raise $86m with IPO

In November last year, gene therapy specialist Orchard Therapeutics raised over $200m, while CAR-T biotech Autolus generated $150m from its IPO in June.

Latest news

CAR-T player Autolus seeks $100m from follow-on financing

After a $100m initial public offering last year, Autolus is sitting on upwards of $200m ahead of the follow-on financing. ... to raise additional capital in order to develop and commercialize our product candidates,” said Autolus in an filing with the
Autolus’ next-gen CAR-T looks promising in ALL

Safety profile could bring greater market potential. UK biotech Autolus seems to be on track to develop a next generation of safer and equally, if not more, efficacious CAR-T therapies. ... Autolus is hoping that AUTO1 will change that, and its first
Novartis and Syncona back new Swiss biotech Anaveon

Autolus, which raised $150m in its IPO last June.
UK biotech booms in 2018, despite Brexit worries

Industry attracted a record-breaking £2.2bn in investment last year
UK’s genomics leadership attracts IQVIA investment, regardless of Brexit

Roche, Celgene and Autolus.

More from news
Approximately 5 fully matching, plus 9 partially matching documents found.

Latest appointments

Former Roche development head joins Asana advisory board

The founder of KAPital Consulting, Dr Dhingra currently serves on the boards of Exosome Diagnostics as chairman of the board, Advanced Accelerator Applications, Five Prime and Autolus.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Understanding the evolving CAR-T market

More than 500 CAR-Ts are in development, making competition fierce. Earlier this year Autolus was forced to delay and even discontinue molecules in its CAR-T pipeline due to both ... The clinical data readout for the AUTO5 trial showed that it “may not

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Editorial Team Leader – Medical Communications – Buckinghamshire...: Salary TBC

Medical Writer – Very Flexible Working – Surrey: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Graduate Scientific Editor: DOE

Senior Editor - Medical Communications - South East - Buckingham...: Highly competitive salary &package

Scientific Director - Medical Communications - Berkshire: Excellent package on offer

Account Supervisor: Salary TBC

Senior Medical Writer: Salary TBC

Account Director, Medical Education: Salary TBC

Entry Level Editorial Assistant – Medical Education –Buckinghams...: Highly Competitive

Account Executive: Salary TBC

Account Director: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail: We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?: Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Strengthening business competition and reducing anti-competitive practices: How the CMA is tackling high prices for essential drugs...

Quick links

Infographics

Multimedia

<>